| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Mats W Johansson | |
| P2860 | cites work | alphadbeta2 integrin is expressed on human eosinophils and functions as an alternative ligand for vascular cell adhesion molecule 1 (VCAM-1) | Q22008473 |
| Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals | Q24595853 | ||
| Eosinophilic bioactivities in severe asthma | Q26744175 | ||
| Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases | Q26767423 | ||
| Periostin and TGF-β-induced protein: Two peas in a pod? | Q26796543 | ||
| Activation states of blood eosinophils in asthma | Q26853383 | ||
| Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge | Q28215560 | ||
| Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids | Q30480169 | ||
| Expression of FcgammaRIII (CD16) on human peripheral blood eosinophils increases in allergic conditions | Q30700025 | ||
| IL-5 induces suspended eosinophils to undergo unique global reorganization associated with priming | Q33799642 | ||
| IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human Eosinophils | Q34489670 | ||
| A role for eosinophils in airway remodelling in asthma | Q34550355 | ||
| Safety of and cellular response to segmental bronchoprovocation in allergic asthma | Q34558188 | ||
| A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia | Q34997750 | ||
| Eosinophils: changing perspectives in health and disease | Q35170969 | ||
| Activation of beta1 integrins on blood eosinophils by P-selectin | Q35528037 | ||
| Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma | Q35813671 | ||
| Current and future biomarkers in allergic asthma | Q35878914 | ||
| Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics | Q36001230 | ||
| Anti-IL-5 attenuates activation and surface density of β(2) -integrins on circulating eosinophils after segmental antigen challenge. | Q36630280 | ||
| Integrin activation States and eosinophil recruitment in asthma | Q36729848 | ||
| Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients | Q36765753 | ||
| Eosinophil trafficking in allergy and asthma. | Q36811728 | ||
| α(M)β(2) integrin-mediated adhesion and motility of IL-5-stimulated eosinophils on periostin. | Q36842950 | ||
| Allergen inhalation challenge: a human model of asthma exacerbation | Q36904204 | ||
| Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma | Q36955887 | ||
| Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge | Q36980346 | ||
| Lung-resident eosinophils represent a distinct regulatory eosinophil subset | Q37217521 | ||
| Semaphorin 7A is expressed on airway eosinophils and upregulated by IL-5 family cytokines | Q37625993 | ||
| Cluster analysis and clinical asthma phenotypes. | Q37711387 | ||
| Mepolizumab and exacerbations of refractory eosinophilic asthma | Q37711391 | ||
| Targeting eosinophils in allergy, inflammation and beyond | Q38075409 | ||
| Clinical utility of asthma biomarkers: from bench to bedside | Q38134713 | ||
| Eosinophilic phenotypes of airway disease | Q38169241 | ||
| Stratified medicine in inflammatory disorders: From theory to practice | Q38454430 | ||
| Leading from the Back: The Role of the Uropod in Neutrophil Polarization and Migration. | Q38908789 | ||
| A Mathematical Modeling Approach to Understanding the Effect of Anti-Interleukin Therapy on Eosinophils | Q40067123 | ||
| CD48 on blood leukocytes and in serum of asthma patients varies with severity. | Q40446568 | ||
| Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial | Q40693199 | ||
| Similar activation state of neutrophils in sputum of asthma patients irrespective of sputum eosinophilia | Q40763965 | ||
| A hidden residential cell in the lung | Q40976019 | ||
| CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils | Q41031721 | ||
| Serum periostin is associated with type 2 immunity in severe asthma | Q41590591 | ||
| Dissection of the hyperadhesive phenotype of airway eosinophils in asthma | Q41975092 | ||
| RNA Seq profiling reveals a novel expression pattern of TGF-β target genes in human blood eosinophils. | Q42776997 | ||
| Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders | Q43669687 | ||
| Expression of activated Fc gamma RII discriminates between multiple granulocyte-priming phenotypes in peripheral blood of allergic asthmatic subjects | Q44062504 | ||
| Differential regulation of aminopeptidase N (CD13) by transendothelial migration and cytokines on human eosinophils | Q44294406 | ||
| Mepolizumab for prednisone-dependent asthma with sputum eosinophilia | Q46098864 | ||
| Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. | Q46547661 | ||
| Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial | Q47249808 | ||
| Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge | Q47803593 | ||
| CD11b and L-selectin expression on eosinophils and neutrophils in blood and induced sputum of patients with asthma compared with normal subjects | Q47914744 | ||
| Diagnosing eosinophilic asthma using a multivariate prediction model based on blood granulocyte responsiveness | Q48010388 | ||
| IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation. | Q48014771 | ||
| Glucagon-like peptide-1 receptor expression on human eosinophils and its regulation of eosinophil activation. | Q48024722 | ||
| IL-5-stimulated eosinophils adherent to periostin undergo stereotypic morphological changes and ADAM8-dependent migration | Q48318859 | ||
| IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. | Q50335900 | ||
| Enhanced expression of neuropeptide S (NPS) receptor in eosinophils from severe asthmatics and subjects with total IgE above 100IU/ml. | Q50800120 | ||
| Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils. | Q51642669 | ||
| Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. | Q52669715 | ||
| Phenotypic plasticity and targeting of Siglec-F(high) CD11c(low) eosinophils to the airway in a murine model of asthma. | Q52913728 | ||
| IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma. | Q54577619 | ||
| CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines | Q55094049 | ||
| Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR | Q56507941 | ||
| Distinctive Blood Eosinophilic Phenotypes and Cytokine Patterns in Eosinophilic Esophagitis, Inflammatory Bowel Disease and Airway Allergy | Q58848601 | ||
| CD69 surface expression on human lung eosinophils after segmental allergen provocation. | Q64912718 | ||
| Altered adhesion molecule expression and endothelial cell activation accompany the recruitment of human granulocytes to the lung after segmental antigen challenge | Q67542329 | ||
| Comparison of airway and blood eosinophil function after in vivo antigen challenge | Q67887085 | ||
| Comparison of surface antigens on eosinophils from patients with eosinophilia | Q71754401 | ||
| Effect of isolation protocol on eosinophil function: Percoll gradients versus immunomagnetic beads | Q71771054 | ||
| Down modulation of L‐Selectin expression on eosinophils recovered from bronchoalveolar lavage fluid after allergen provocation | Q72076916 | ||
| Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production | Q72376935 | ||
| Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics | Q72768467 | ||
| Eosinophils from patients with asthma express higher levels of the pan-leucocyte receptor CD45 and the isoform CD45RO | Q73667011 | ||
| CD44 expression on blood eosinophils is a novel marker of bronchial asthma | Q73863423 | ||
| Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells | Q74595805 | ||
| LFA-1 expression by blood eosinophils is increased in atopic asthmatic children and is involved in eosinophil locomotion | Q77720141 | ||
| Increased CD69 expression on peripheral blood eosinophils after specific inhalation challenge | Q77999484 | ||
| CD48 is an allergen and IL-3-induced activation molecule on eosinophils | Q79754943 | ||
| Eosinophil beta 1 integrin activation state correlates with asthma activity in a blind study of inhaled corticosteroid withdrawal | Q83917010 | ||
| T Cells localize with proliferating smooth muscle alpha-actin+ cell compartments in asthma | Q84068795 | ||
| Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma | Q86248010 | ||
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 75 | |
| P577 | publication date | 2017-06-12 | |
| P1433 | published in | Frontiers in Medicine | Q27726181 |
| P1476 | title | Eosinophil Activation Status in Separate Compartments and Association with Asthma | |
| P478 | volume | 4 |
| Q55003087 | Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma. |
| Q50046297 | Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD. |
| Q89027053 | Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge |
| Q89495543 | Effect of neuromedin U on allergic airway inflammation in an asthma model |
| Q64095605 | Glucagon reduces airway hyperreactivity, inflammation, and remodeling induced by ovalbumin |
| Q90190381 | In Vivo Allergen-Activated Eosinophils Promote Collagen I and Fibronectin Gene Expression in Airway Smooth Muscle Cells via TGF-β1 Signaling Pathway in Asthma |
| Q92536062 | Interleukin-5 in the Pathophysiology of Severe Asthma |
| Q64057019 | Intravital imaging allows real-time characterization of tissue resident eosinophils |
| Q90259051 | Metabolic Profiling of Human Eosinophils |
| Q64889881 | Neutrophil heterogeneity and its role in infectious complications after severe trauma. |
| Q52374596 | Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. |
| Q88663963 | Reuse of public, genome-wide, murine eosinophil expression data for hypotheses development |
| Q61959702 | Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD) |
| Q52719312 | Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease. |
| Q52729256 | The Eosinophil: for better or worse, in sickness and in health. |
| Q89468059 | αIIb-Integrin (CD41) associated with blood eosinophils is a potential biomarker for disease activity in eosinophilic esophagitis |
Search more.